Groups | Antibiotic Tested | Sputum (n = 116) | |
Sensitive | Resistance | ||
Aminoglycosides | Gentamicin [G] | 74 (63.80%) | 42 (36.20%) |
Amikacin [Ak] | 74 (63.80%) | 42 (36.20%) | |
Tobramycin [Tb] | 92 (79.32%) | 24 (20.68%) | |
Fluroquinolones | Ciprofloxacin[Ci] | 85 (73%) | 31 (27%) |
Ofloxacin [Of] | 108 (93.10%) | 8 (6.90%) | |
Norfloxacin [Nx] | 108 (93.10%) | 8 (6.90%) | |
Carbapenems | Meropenem [Mi] | 74 (63.80%) | 42 (36.20%) |
Imipenem [I] | 74 (63.80%) | 42 (36.20%) | |
Extended Spectrum Penicillin | Ticarcillin [Ti] | 67 (57.75%) | 49 (42.25%) |
Monobactams | Aztreonam [Ao] | 49 (42.25%) | 67 (57.75%) |
Cephalosporins | Cefepime [Cpm] | 66 (56.90%) | 50 (43.10%) |
Cephotaxime [Ce] | 16 (13.80%) | 100 (86.20%) | |
Cefatazidime [Ca] | 47 (41%) | 69 (59%) |